je.st
news
Novartis Boost Seen in Fast Cancer Drug Review as Protection Ends: Health
2013-05-06 03:24:00| Biotech - Topix.net
Just as Novartis AG 's best-selling medicines are losing patent protection, the company is poised to get a revenue boost from a U.S. program designed to speed life- saving therapies to patients with few treatment options.
Tags: health
review
fast
protection
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||